(IN BRIEF) Amsterdam-based LUMICKS has secured €20 million in venture debt from the European Investment Bank (EIB) to advance its next-generation cell avidity platform, which aims to accelerate the development of immunotherapies for cancer treatment. Supported by the InvestEU initiative, … Read the full press release →
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, Netherlands, News, Science, Technology
Tagged Cancer Drug Discovery, EIB, Hugo de Wit, Immunotherapy Tools, investment, LUMICKS, Netherlands, partnership, Robert de Groot, sustainability